IMWG consensus on risk stratification in multiple myeloma

Shaji K. Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, David Dingli, Stephen J. Russell, John A. Lust, Philip R. Greipp, Robert A. Kyle, Morie A. Gertz, Improved survival in multiple myeloma and the impact of novel therapies Blood. ,vol. 111, pp. 2516- 2520 ,(2008) , 10.1182/BLOOD-2007-10-116129

Craig B. Reeder, Donna E. Reece, Vishal Kukreti, Christine Chen, Suzanne Trudel, Kristina Laumann, Joseph Hentz, Nicholas A. Pirooz, Jesus G. Piza, Rodger Tiedemann, Joseph R. Mikhael, Peter L. Bergsagel, Jose F. Leis, Rafael Fonseca, Alexander K. Stewart, Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma Blood. ,vol. 115, pp. 3416- 3417 ,(2010) , 10.1182/BLOOD-2010-02-271676

Wee J. Chng, Esteban Braggio, George Mulligan, Barbara Bryant, Ellen Remstein, Riccardo Valdez, Ahmet Dogan, Rafael Fonseca, The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition. Blood. ,vol. 111, pp. 1603- 1609 ,(2008) , 10.1182/BLOOD-2007-06-097774

Philippe Moreau, Herve Avet-Loiseau, Thierry Facon, Michel Attal, Mourad Tiab, Cyrille Hulin, Chantal Doyen, Laurent Garderet, Edouard Randriamalala, Carla Araujo, Gérard Lepeu, Gerald Marit, Denis Caillot, Martine Escoffre, Bruno Lioure, Lotfi Benboubker, Brigitte Pégourié, Brigitte Kolb, Anne Marie Stoppa, Jean-Gabriel Fuzibet, Olivier Decaux, Mamoun Dib, Christian Berthou, Carine Chaleteix, Catherine Sebban, Catherine Traullé, Jean Fontan, Marc Wetterwald, Pascal Lenain, Claire Mathiot, Jean-Luc Harousseau, Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma Blood. ,vol. 118, pp. 5752- 5758 ,(2011) , 10.1182/BLOOD-2011-05-355081

Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Hans Salwender, Igor W. Blau, Katja Weisel, Michael Pfreundschuh, Christof Scheid, Ulrich Dührsen, Walter Lindemann, Ingo G. H. Schmidt-Wolf, Norma Peter, Christian Teschendorf, Hans Martin, Mathias Haenel, Hans G. Derigs, Marc S. Raab, Anthony D. Ho, Helgi van de Velde, Dirk Hose, Pieter Sonneveld, Hartmut Goldschmidt, Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p Blood. ,vol. 119, pp. 940- 948 ,(2012) , 10.1182/BLOOD-2011-09-379164

María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Ana López de la Guía, Javier López, Enrique Bengoechea, Montserrat Pérez, Marta Polo, Luis Palomera, Felipe De Arriba, Yolanda González, Jose-Mariano Hernández, Miquel Granell, José-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, José-María Ribera, María-Luisa Martín-Mateos, Ramón García-Sanz, Juan-José Lahuerta, Joan Bladé, Jesús F San-Miguel, None, Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial Blood. ,vol. 120, pp. 2581- 2588 ,(2012) , 10.1182/BLOOD-2012-05-427815

H Avet-Loiseau, BGM Durie, Michele Cavo, Michel Attal, Norma Gutierrez, Jeff Haessler, Hartmut Goldschmidt, Roman Hájek, JH Lee, O Sezer, Bart Barlogie, John Crowley, Rafael Fonseca, Nicoletta Testoni, F Ross, SV Rajkumar, Pieter Sonneveld, J Lahuerta, P Moreau, Gareth Morgan, None, Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project Leukemia. ,vol. 27, pp. 711- 717 ,(2013) , 10.1038/LEU.2012.282

Saad Z. Usmani, Rachel Sexton, Antje Hoering, Christoph J. Heuck, Bijay Nair, Sarah Waheed, Yazan Al Sayed, Nabeel Chauhan, Nisar Ahmad, Shebli Atrash, Nathan Petty, Frits van Rhee, John Crowley, Bart Barlogie, Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. Blood. ,vol. 120, pp. 1597- 1600 ,(2012) , 10.1182/BLOOD-2012-04-421883

Francesca Gay, Alessandra Larocca, Pierre Wijermans, Federica Cavallo, Davide Rossi, Ron Schaafsma, Mariella Genuardi, Alessandra Romano, Anna Marina Liberati, Agostina Siniscalchi, Maria T. Petrucci, Chiara Nozzoli, Francesca Patriarca, Massimo Offidani, Roberto Ria, Paola Omedè, Benedetto Bruno, Roberto Passera, Pellegrino Musto, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo, Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients Blood. ,vol. 117, pp. 3025- 3031 ,(2011) , 10.1182/BLOOD-2010-09-307645

S. Waheed, A. Mitchell, S. Usmani, J. Epstein, S. Yaccoby, B. Nair, R. van Hemert, E. Angtuaco, T. Brown, T. Bartel, J. McDonald, E. Anaissie, F. van Rhee, J. Crowley, B. Barlogie, Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data Haematologica. ,vol. 98, pp. 71- 78 ,(2013) , 10.3324/HAEMATOL.2012.066555